WELL Health Technologies (TSX:WELL) Announces CEO’s Letter to Shareholders

January 21, 2026 — Leads & Copy —

WELL Health Technologies Corp. has released a letter to shareholders from its Founder, Chairman, and CEO, Hamed Shahbazi, outlining strategic priorities for 2026 and growth principles. The digital healthcare company aims to positively impact health outcomes by leveraging technology to empower healthcare practitioners and their patients globally.

The CEO letter is accessible on the company’s website.

WELL’s mission is to tech-enable healthcare providers by developing technologies, services, and support. Its healthcare and digital platform includes front and back-office management software applications that help physicians run and secure their practices. WELL’s solutions enable more than 43,000 healthcare providers between the US and Canada and power the largest owned and operated healthcare ecosystem in Canada with more than 240 clinics supporting primary care, specialized care, and diagnostic services. In the United States, WELL’s solutions are focused on specialized markets such as the gastrointestinal market, women’s health, primary care, and mental health.

WELL is publicly traded on the Toronto Stock Exchange under the symbol “WELL” and on the OTC Exchange under the symbol “WHTCF”.

Hamed Shahbazi, Chief Executive Officer, Chairman and Director

Contact:

Hamed Shahbazi

Chief Executive Officer, Chairman and Director

Source: WELL Health Technologies Corp.

×

Welcome!

BiotechReporter.news is a Leads & Copy Publication

Leads & Copy is a Media “news tip” source, providing Industry Reporters story Leads, written as Publishable CP-style Copy.

By Subscribing you will receive Daily Biotech Story Leads via email 10:30 am Mon-Fri.